Regeneron Pharmaceuticals

REGN · Health Care

Sustainability score

52.6Rank 225 overall / 24 in Health Care

Regeneron Pharmaceuticals's distance from the ideal is driven mostly by Asset turnover and FCF margin. It sits closest to the frontier on Net debt / EBITDA.

55th percentile of the index, 60th percentile of Health Care

Environmental

Social

Financial/Operational

Distance-to-ideal decomposition

Emissions intensity

13%

ESG risk score

11%

Controversy level

Asset turnover

43%

Net margin

FCF margin

25%

Net debt / EBITDA

Pillar weight shares: Environmental 24%, Social 23%, Financial/Operational 53%

Generating AI analysis...

Net-zero scenario

REGN · Regeneron Pharmaceuticals

Middle · middle 60% of Health Care · score 65.6 · rank 31/59

Cleanup cost: 0.00 yrs · n/a; Sector median 0.00 yrs
Revenue at risk: 0%; Sector median 0%
Revenue upside: 0%; Sector median 0%
Can it pay: 0.0x debt load; FCF margin 23% · sector median 2.1x

Verdict: HOLDNo position to stressData: estimatedHeld at benchmark

Cleanup bill by source

Purchased electricity	n/a
On-site fuel combustion	n/a
Vehicle fleets	n/a
Process emissions	n/a
Fugitive emissions	n/a

Why

Benchmark: burden 0.00 years of earnings (sector median 0.00 years), fossil revenue 0%, beneficiary revenue 0%, net debt/EBITDA 0.0x; largest gaps to the sector ideal: transition burden and leverage vs sector target.

Regeneron Pharmaceuticals

Sustainability score

Net-zero scenario

REGN · Regeneron Pharmaceuticals

Cleanup bill by source

Why

Health Care peers

Key takeaways

Explanation

Regeneron Pharmaceuticals

Sustainability score

Net-zero scenario

REGN · Regeneron Pharmaceuticals

Cleanup bill by source

Why

Health Care peers

Key takeaways

Explanation